MedPath

Effectiveness of homoeopathic medicine Guatteria gaumeri in cases of Dyslipidemia

Phase 3
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Registration Number
CTRI/2024/05/066738
Lead Sponsor
Dr. Tanya Wadhwa National Institute of Homoeopathy, Kolkata
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. The patents with low (10%) and intermediate (10-19%) risk in Framingham score (estimation of 10 years CVD risk) will be included in the study.

2. Patients of all genders, different religions and socio-economic groups.

3. Patients of age group 20-60 years.

4. Patients with serum LDL levels between 100-200 mg/dl.

5. Patients willing to give written consent for participating in the study.

Exclusion Criteria

1. Patients with high risk (= 20%) in Framingham Risk score.

2. Patients taking statin therapy.

3. Patients having systemic illness, malignancy, immuno-compromised state, psychiatric illness.

4. Patients who are pregnant, lactating, or taking oral contraceptive pills or hormonal therapy.

5. Patients taking anti-diabetic and/or anti-hypertensive medicines.

6. Patients unwilling to take part or give consent for the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum LDL levelsTimepoint: At the baseline and after 3 months of treatment
Secondary Outcome Measures
NameTimeMethod
Modified Naranjo Criteria for Homeopathy (MONARCH).Timepoint: After 3 months of treatment
© Copyright 2025. All Rights Reserved by MedPath